Translational Research


Project Grants

Investigation of the role of lymph node metastasis in initiation and progression of bone metastasis 2018 - 2019
A personalised PSA test for prostate cancer diagnosis 2017 - 2019
Targeting a master regulator of tumour cell plasticity as a new adjuvant therapy for prostate cancer 2016 - 2018
Functional and mechanistic characterisation of a novel LncRNA at chromosomal locus 5p15 in prostate cancer 2017 - 2018
High-content screening of small molecule inhibitors from nature that target prostate cancer metabolism 2017 - 2018
Association analysis of microRNA related genetic variations with risk and prognosis of prostate cancer 2017 - 2018
Discovery of new therapeutic targets for aggressive prostate cancer 2018 - 2018
Exploring the role of miRSNPs in diagnosis and prognosis of prostate cancer 2015 - 2017
Targeting neuropilin-1 to inhibit prostate cancer metastasis and therapy resistance 2015 - 2017
The ghrelin receptor antisense long non-coding RNA gene, GHSROS, as a potential target for prostate cancer therapy 2016 - 2017
High-content screening of small molecule inhibitors from nature that target prostate cancer metabolism 2017 - 2017
Novel microRNAs as potential targets for treating prostate cancer 2017 - 2017
hSSB1: A key regulator of genome stability and potential cancer therapeutic target 2014 - 2016
The ghrelin axis as a target for prostate cancer therapy 2014 - 2016
Development of YB-1 as a therapeutic target in advanced prostate cancer 2015 - 2016
PSA Coding variants: Functional analysis, multiethnic association and risk models for prostate cancer 2015 - 2016
KLK14 as a novel therapeutic target in muscle wasting induced by androgen deprivation therapy 2016 - 2016
Circulating long noncoding RNA as diagnostic and prognostic biomarkers for prostate cancer 2015 - 2016
Characterising insulin signalling in androgen-deprived prostate cancer cells 2014 - 2015
Defining the role of the PSA-related Kallikrein serine proteases in hormone dependent cancer progression 2011 - 2015
Targeting leptin in prostate cancer progression; linking metabolic dysfunction and castrate resistance 2014 - 2015
To study how prostate tumour metastasizes to bone 2012 - 2015
KLK4 is a key regulator of the reactive stromal microenvironment in prostate cancer 2014 - 2015
Identification and characterisation of a genetic signature at the 5p15 region associated with prostate cancer across ethnic groups 2013 - 2015
miSNPs as novel diagnostic and prognostic biomarkers for prostate cancer 2014 - 2015
Endeavour Research Fellowship 2015 - 2015
MyRIP and exosomes function to control genomic stability 2014 - 2015
A new hierarchy of mathematical models to quantify the role of ghrelin during cell invasion 2014 - 2014
Circulating Tumour Cells Collaborative Prostate Cancer Biomarker Project 2013 - 2014
Development of assays for the capture and detection of prostate cancer-derived exosomes and exosomal markers 2013 - 2014
Development of new therapeutic approaches for prostate cancer progression - dissecting the effects of diabetes and obesity in cancer progression 2009 - 2014
Engineering a High-Throughput Prostate Cancer Stem Cell Niche Mimic 2013 - 2014
Exosome biomarkers: Defining prognosis for drug- and castrate-resistant prostate cancer 2012 - 2014
To identify a new therapeutic target for the treatment of prostate cancer 2012 - 2014
Identification of RNA species regulated by YB-1 and G3BPs in prostate cancer cells 2011 - 2012